vs
Side-by-side financial comparison of ASTRONICS CORP (ATRO) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
ASTRONICS CORP is the larger business by last-quarter revenue ($240.1M vs $123.8M, roughly 1.9× NATURES SUNSHINE PRODUCTS INC). On growth, ASTRONICS CORP posted the faster year-over-year revenue change (15.1% vs 4.7%). ASTRONICS CORP produced more free cash flow last quarter ($15.8M vs $7.6M). Over the past eight quarters, ASTRONICS CORP's revenue compounded faster (13.9% CAGR vs 5.6%).
Astronics Corporation is an American aerospace electronics corporation founded in 1968, headquartered in East Aurora, New York. It is traded on NASDAQ as Nasdaq: ATRO. It is known for lighting and electronics integrations on military, commercial, and business aircraft and semiconductor test systems.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
ATRO vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $240.1M | $123.8M |
| Net Profit | — | $4.1M |
| Gross Margin | 33.3% | 72.5% |
| Operating Margin | 14.8% | 4.3% |
| Net Margin | — | 3.3% |
| Revenue YoY | 15.1% | 4.7% |
| Net Profit YoY | — | 1379.4% |
| EPS (diluted) | $0.82 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $240.1M | $123.8M | ||
| Q3 25 | $211.4M | $128.3M | ||
| Q2 25 | $204.7M | $114.8M | ||
| Q1 25 | $205.9M | $113.2M | ||
| Q4 24 | $208.5M | $118.2M | ||
| Q3 24 | $203.7M | $114.6M | ||
| Q2 24 | $198.1M | $110.6M | ||
| Q1 24 | $185.1M | $111.0M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | $-11.1M | $5.3M | ||
| Q2 25 | $1.3M | $5.3M | ||
| Q1 25 | $9.5M | $4.7M | ||
| Q4 24 | — | $-321.0K | ||
| Q3 24 | $-11.7M | $4.3M | ||
| Q2 24 | $1.5M | $1.3M | ||
| Q1 24 | $-3.2M | $2.3M |
| Q4 25 | 33.3% | 72.5% | ||
| Q3 25 | 30.5% | 73.3% | ||
| Q2 25 | 25.8% | 71.7% | ||
| Q1 25 | 29.5% | 72.1% | ||
| Q4 24 | 29.8% | 72.0% | ||
| Q3 24 | 27.1% | 71.3% | ||
| Q2 24 | 28.0% | 71.4% | ||
| Q1 24 | 25.7% | 71.2% |
| Q4 25 | 14.8% | 4.3% | ||
| Q3 25 | 10.9% | 7.0% | ||
| Q2 25 | 2.3% | 3.7% | ||
| Q1 25 | 6.4% | 5.4% | ||
| Q4 24 | 4.3% | 3.8% | ||
| Q3 24 | 4.1% | 4.6% | ||
| Q2 24 | 3.8% | 5.1% | ||
| Q1 24 | 0.9% | 4.2% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | -5.2% | 4.2% | ||
| Q2 25 | 0.6% | 4.6% | ||
| Q1 25 | 4.6% | 4.2% | ||
| Q4 24 | — | -0.3% | ||
| Q3 24 | -5.8% | 3.8% | ||
| Q2 24 | 0.8% | 1.2% | ||
| Q1 24 | -1.7% | 2.1% |
| Q4 25 | $0.82 | $0.23 | ||
| Q3 25 | $-0.31 | $0.30 | ||
| Q2 25 | $0.04 | $0.28 | ||
| Q1 25 | $0.26 | $0.25 | ||
| Q4 24 | $-0.07 | $-0.02 | ||
| Q3 24 | $-0.34 | $0.23 | ||
| Q2 24 | $0.04 | $0.07 | ||
| Q1 24 | $-0.09 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.2M | $93.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $140.1M | $161.6M |
| Total Assets | $706.7M | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $93.9M | ||
| Q3 25 | $13.5M | $95.6M | ||
| Q2 25 | $13.5M | $81.3M | ||
| Q1 25 | $24.8M | $86.5M | ||
| Q4 24 | $9.3M | $84.7M | ||
| Q3 24 | $5.2M | $78.7M | ||
| Q2 24 | $2.9M | $68.7M | ||
| Q1 24 | $5.3M | $77.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.1M |
| Q4 25 | $140.1M | $161.6M | ||
| Q3 25 | $108.9M | $166.7M | ||
| Q2 25 | $271.6M | $163.7M | ||
| Q1 25 | $266.8M | $167.1M | ||
| Q4 24 | $256.1M | $161.0M | ||
| Q3 24 | $249.2M | $162.6M | ||
| Q2 24 | $257.9M | $156.4M | ||
| Q1 24 | $251.7M | $159.7M |
| Q4 25 | $706.7M | $261.1M | ||
| Q3 25 | $682.2M | $264.8M | ||
| Q2 25 | $646.7M | $254.9M | ||
| Q1 25 | $662.2M | $252.7M | ||
| Q4 24 | $648.8M | $240.9M | ||
| Q3 24 | $651.6M | $245.3M | ||
| Q2 24 | $644.9M | $235.8M | ||
| Q1 24 | $630.0M | $247.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.6M | $9.9M |
| Free Cash FlowOCF − Capex | $15.8M | $7.6M |
| FCF MarginFCF / Revenue | 6.6% | 6.1% |
| Capex IntensityCapex / Revenue | 4.9% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.6M | $9.9M | ||
| Q3 25 | $34.2M | $18.5M | ||
| Q2 25 | $-7.6M | $4.3M | ||
| Q1 25 | $20.6M | $2.6M | ||
| Q4 24 | $26.4M | $12.2M | ||
| Q3 24 | $8.4M | $9.6M | ||
| Q2 24 | $-6.3M | $1.3M | ||
| Q1 24 | $2.0M | $2.2M |
| Q4 25 | $15.8M | $7.6M | ||
| Q3 25 | $21.0M | $16.8M | ||
| Q2 25 | $-12.2M | $3.0M | ||
| Q1 25 | $18.5M | $1.5M | ||
| Q4 24 | $23.2M | $10.0M | ||
| Q3 24 | $6.5M | $7.9M | ||
| Q2 24 | $-8.1M | $-2.0M | ||
| Q1 24 | $439.0K | $-1.5M |
| Q4 25 | 6.6% | 6.1% | ||
| Q3 25 | 9.9% | 13.1% | ||
| Q2 25 | -6.0% | 2.6% | ||
| Q1 25 | 9.0% | 1.3% | ||
| Q4 24 | 11.1% | 8.5% | ||
| Q3 24 | 3.2% | 6.9% | ||
| Q2 24 | -4.1% | -1.9% | ||
| Q1 24 | 0.2% | -1.4% |
| Q4 25 | 4.9% | 1.9% | ||
| Q3 25 | 6.2% | 1.3% | ||
| Q2 25 | 2.2% | 1.2% | ||
| Q1 25 | 1.0% | 1.0% | ||
| Q4 24 | 1.5% | 1.9% | ||
| Q3 24 | 0.9% | 1.5% | ||
| Q2 24 | 0.9% | 3.0% | ||
| Q1 24 | 0.9% | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | -5.81× | 0.81× | ||
| Q1 25 | 2.17× | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | -4.08× | 0.97× | ||
| Q1 24 | — | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
